WO2023002252A1 - Composition comprenant des bêta-glucanes et des alpha-fucanes pour amélioration de la santé intestinale et des performances animales et leurs procédés de fabrication - Google Patents
Composition comprenant des bêta-glucanes et des alpha-fucanes pour amélioration de la santé intestinale et des performances animales et leurs procédés de fabrication Download PDFInfo
- Publication number
- WO2023002252A1 WO2023002252A1 PCT/IB2022/000421 IB2022000421W WO2023002252A1 WO 2023002252 A1 WO2023002252 A1 WO 2023002252A1 IB 2022000421 W IB2022000421 W IB 2022000421W WO 2023002252 A1 WO2023002252 A1 WO 2023002252A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glucans
- composition
- fucans
- gut
- animal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 162
- 241001465754 Metazoa Species 0.000 title claims abstract description 96
- 238000000034 method Methods 0.000 title claims abstract description 77
- 229920002498 Beta-glucan Polymers 0.000 title abstract description 6
- 230000036541 health Effects 0.000 title description 19
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 90
- 235000019621 digestibility Nutrition 0.000 claims abstract description 64
- 230000012010 growth Effects 0.000 claims abstract description 58
- 230000009286 beneficial effect Effects 0.000 claims abstract description 47
- 241000588724 Escherichia coli Species 0.000 claims abstract description 46
- 235000015097 nutrients Nutrition 0.000 claims abstract description 39
- 230000002829 reductive effect Effects 0.000 claims abstract description 38
- 206010061218 Inflammation Diseases 0.000 claims abstract description 33
- 230000004054 inflammatory process Effects 0.000 claims abstract description 33
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 30
- 239000011707 mineral Substances 0.000 claims abstract description 30
- 238000010521 absorption reaction Methods 0.000 claims abstract description 28
- 208000015181 infectious disease Diseases 0.000 claims abstract description 28
- 241000607142 Salmonella Species 0.000 claims abstract description 26
- 230000001976 improved effect Effects 0.000 claims abstract description 25
- 210000000936 intestine Anatomy 0.000 claims abstract description 20
- 230000002195 synergetic effect Effects 0.000 claims abstract description 20
- 229920001503 Glucan Polymers 0.000 claims description 163
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 79
- 239000008101 lactose Substances 0.000 claims description 79
- 241001474374 Blennius Species 0.000 claims description 78
- 241000282412 Homo Species 0.000 claims description 36
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims description 32
- 229920001543 Laminarin Polymers 0.000 claims description 32
- 239000005717 Laminarin Substances 0.000 claims description 31
- 239000003242 anti bacterial agent Substances 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 31
- 229940088710 antibiotic agent Drugs 0.000 claims description 29
- 238000000605 extraction Methods 0.000 claims description 28
- 230000003612 virological effect Effects 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 22
- 239000006041 probiotic Substances 0.000 claims description 21
- 235000018291 probiotics Nutrition 0.000 claims description 21
- 241000186000 Bifidobacterium Species 0.000 claims description 16
- 229920000855 Fucoidan Polymers 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 15
- 229930195725 Mannitol Natural products 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000594 mannitol Substances 0.000 claims description 14
- 235000010355 mannitol Nutrition 0.000 claims description 14
- 230000000529 probiotic effect Effects 0.000 claims description 14
- 241001466453 Laminaria Species 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 241000512260 Ascophyllum Species 0.000 claims description 6
- MSXHSNHNTORCAW-MPGIDXPLSA-M sodium;(3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].O[C@@H]1OC(C([O-])=O)[C@@H](O)[C@H](O)[C@@H]1O MSXHSNHNTORCAW-MPGIDXPLSA-M 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 241000206576 Chondrus Species 0.000 claims description 4
- 241001147462 Gigartinaceae Species 0.000 claims description 4
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 241001466452 Laminariaceae Species 0.000 claims description 4
- 241001491708 Macrocystis Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 241001512723 Ecklonia Species 0.000 claims description 3
- 241000195482 Fucaceae Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000005911 diet Nutrition 0.000 description 97
- 230000000694 effects Effects 0.000 description 81
- 241000282887 Suidae Species 0.000 description 72
- 230000037213 diet Effects 0.000 description 67
- 239000000284 extract Substances 0.000 description 52
- 235000013406 prebiotics Nutrition 0.000 description 49
- 241000894006 Bacteria Species 0.000 description 32
- 210000003608 fece Anatomy 0.000 description 32
- 230000000378 dietary effect Effects 0.000 description 30
- 235000010755 mineral Nutrition 0.000 description 24
- 230000009469 supplementation Effects 0.000 description 24
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 23
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 23
- 229920001282 polysaccharide Polymers 0.000 description 23
- 239000005017 polysaccharide Substances 0.000 description 23
- 150000004804 polysaccharides Chemical class 0.000 description 22
- 241001673669 Porcine circovirus 2 Species 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 20
- 230000008569 process Effects 0.000 description 20
- 241000282898 Sus scrofa Species 0.000 description 19
- 230000006872 improvement Effects 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 241000702619 Porcine parvovirus Species 0.000 description 16
- 230000000813 microbial effect Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 241000124008 Mammalia Species 0.000 description 14
- 239000000835 fiber Substances 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000002550 fecal effect Effects 0.000 description 12
- 230000003993 interaction Effects 0.000 description 12
- 150000001720 carbohydrates Chemical class 0.000 description 11
- 235000014633 carbohydrates Nutrition 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 235000013339 cereals Nutrition 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 235000010443 alginic acid Nutrition 0.000 description 9
- 229920000615 alginic acid Polymers 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 210000001072 colon Anatomy 0.000 description 9
- 230000009021 linear effect Effects 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 241000199919 Phaeophyceae Species 0.000 description 8
- 238000001728 nano-filtration Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 240000005979 Hordeum vulgare Species 0.000 description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 description 7
- 241000186660 Lactobacillus Species 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 235000019755 Starter Diet Nutrition 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 7
- 230000000845 anti-microbial effect Effects 0.000 description 7
- 239000004599 antimicrobial Substances 0.000 description 7
- 238000011999 immunoperoxidase monolayer assay Methods 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 239000006054 starter diet Substances 0.000 description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000007319 Avena orientalis Nutrition 0.000 description 6
- 244000075850 Avena orientalis Species 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 229940072056 alginate Drugs 0.000 description 6
- 239000003599 detergent Substances 0.000 description 6
- 239000006052 feed supplement Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 244000005709 gut microbiome Species 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 238000007619 statistical method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 241001598113 Laminaria digitata Species 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000688 enterotoxigenic effect Effects 0.000 description 5
- 230000020477 pH reduction Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 241000512259 Ascophyllum nodosum Species 0.000 description 4
- 241000252983 Caecum Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- -1 Fructose oligosaccharides Chemical class 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 210000004534 cecum Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 235000013369 micronutrients Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 101710146739 Enterotoxin Proteins 0.000 description 3
- 241000296380 Laminaria hyperborea Species 0.000 description 3
- 206010039438 Salmonella Infections Diseases 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000006053 animal diet Substances 0.000 description 3
- 239000006030 antibiotic growth promoter Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 230000000112 colonic effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000147 enterotoxin Substances 0.000 description 3
- 231100000655 enterotoxin Toxicity 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000001630 jejunum Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011785 micronutrient Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000005416 organic matter Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 206010039447 salmonellosis Diseases 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000004258 Ethoxyquin Substances 0.000 description 2
- 229930191978 Gibberellin Natural products 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 208000012927 adermatoglyphia Diseases 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000004062 cytokinin Substances 0.000 description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000006047 digesta Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000019285 ethoxyquin Nutrition 0.000 description 2
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 2
- 229940093500 ethoxyquin Drugs 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000006056 finisher diet Substances 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 2
- 239000003448 gibberellin Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000009309 intensive farming Methods 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000009991 scouring Methods 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 235000000891 standard diet Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 235000019722 synbiotics Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000024244 Chelis Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 241000258955 Echinodermata Species 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 101001133081 Homo sapiens Mucin-2 Proteins 0.000 description 1
- 229920000869 Homopolysaccharide Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034263 Mucin-2 Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241000500340 Pediococcus damnosus Species 0.000 description 1
- 241000604136 Pediococcus sp. Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000983746 Saccharina latissima Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SHZGCJCMOBCMKK-SXUWKVJYSA-N alpha-L-fucose Chemical group C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-SXUWKVJYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940075599 ascophyllum nodosum extract Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000020856 atkins diet Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000001200 fecal consistency Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 101150079178 log gene Proteins 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 108010005335 mannoproteins Proteins 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 102000030592 phosphoserine aminotransferase Human genes 0.000 description 1
- 108010088694 phosphoserine aminotransferase Proteins 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000014745 severe cutaneous adverse reaction Diseases 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une composition et des procédés comprenant une quantité de β-glucanes et d'α-fucanes, dans lesquels la combinaison est synergique pour au moins l'un des effets suivants : l'augmentation de la croissance des microbes bénéfiques et la réduction des concentrations de microbes nuisibles choisis parmi le E. coli ou le Salmonella dans les intestins animaux ou humains, l'amélioration de la structure intestinale, la réduction de l'inflammation intestinale, l'amélioration de la digestibilité des nutriments, l'amélioration de l'absorption des minéraux et des performances de croissance, ou la réduction de l'infection et de l'inflammation intestinales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/382,000 | 2021-07-21 | ||
| US17/382,000 US20210346443A1 (en) | 2005-11-21 | 2021-07-21 | Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023002252A1 true WO2023002252A1 (fr) | 2023-01-26 |
Family
ID=83049911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2022/000421 WO2023002252A1 (fr) | 2021-07-21 | 2022-07-20 | Composition comprenant des bêta-glucanes et des alpha-fucanes pour amélioration de la santé intestinale et des performances animales et leurs procédés de fabrication |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2023002252A1 (fr) |
Citations (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB727013A (en) | 1949-11-28 | 1955-03-30 | Nat Res Dev | An improved process for the extraction of mannitol, laminarin and alginic acid from seaweed |
| US4739046A (en) | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
| US4761042A (en) | 1986-02-25 | 1988-08-02 | Alfred Teves Gmbh | Anti-lock hydraulic brake system |
| US4891220A (en) | 1988-07-14 | 1990-01-02 | Immudyne, Inc. | Method and composition for treating hyperlipidemia |
| US5591428A (en) | 1991-07-25 | 1997-01-07 | Probi Ab | Intestine colonizing lactobacilli |
| US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
| US5633369A (en) | 1989-09-08 | 1997-05-27 | Alpha-Beta Technology, Inc. | Method for producing soluble glucans |
| US5705184A (en) | 1995-03-02 | 1998-01-06 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
| US6143731A (en) | 1989-10-20 | 2000-11-07 | The Collaborative Group, Ltd. | Glucan dietary additives |
| US6214337B1 (en) | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
| US6270812B1 (en) | 2000-01-31 | 2001-08-07 | Texas Tech University | Reducing E. coli content of beef |
| US20010016220A1 (en) | 1999-12-22 | 2001-08-23 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Encapsulated multifunctional biologically active food component, process for its production and its use |
| US6312709B1 (en) | 1998-02-27 | 2001-11-06 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US6342242B1 (en) | 1998-02-27 | 2002-01-29 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US6383538B1 (en) | 1998-02-27 | 2002-05-07 | Texas Tech University | Producing meat with enhanced shelf-life |
| US6391331B1 (en) | 1998-02-27 | 2002-05-21 | Texas Tech University | Direct feeding of seaweed supplement to cattle and swine to enhance carcass quality |
| US20020143174A1 (en) | 1998-09-25 | 2002-10-03 | Biopolymer Engineering, Inc. | Very high molecular weight beta-glucans |
| US20020146484A1 (en) | 2001-01-02 | 2002-10-10 | Fidler Daniel J. | Concentrated spent fermentation beer of saccharopolyspora erythraea activated by an enzyme mixture as a nutitional feed supplement |
| US20030119780A1 (en) | 2001-11-30 | 2003-06-26 | Jean-Claude Yvin | Therapeutical treatments |
| US20030124170A1 (en) | 2001-12-19 | 2003-07-03 | Gallaher Daniel D. | Methods to reduce body fat |
| US20030219468A1 (en) | 2002-05-21 | 2003-11-27 | Raczek Nico N. | B-glucan-containing sorbic acid preparation as feed additive in farm animal rearing |
| US20040008253A1 (en) | 2002-07-10 | 2004-01-15 | Monroe David A. | Comprehensive multi-media surveillance and response system for aircraft, operations centers, airports and other commercial transports, centers and terminals |
| US20040058889A1 (en) | 2002-09-20 | 2004-03-25 | Nino Sorgente | Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| US20040082539A1 (en) | 1995-03-13 | 2004-04-29 | Novogen Research Party, Ltd. | Novel therapeutic uses of glucan |
| US20040086491A2 (en) | 2002-02-05 | 2004-05-06 | Corpak Medsystems, Inc. | Probiotic/Prebiotic Composition and Delivery Method |
| US20040127457A1 (en) | 2000-11-03 | 2004-07-01 | Jean-Claude Yvin | Anti-inflammatory and healing medicine based on laminarin sulphate |
| US20040138172A1 (en) | 2001-06-01 | 2004-07-15 | Yukie Murata | Drug product for intestinal disease |
| US20040253253A1 (en) | 2003-06-11 | 2004-12-16 | Cheung Ling Yuk | Biological compositions and methods for treatment of stomach cancer |
| US20050020490A1 (en) | 2004-10-18 | 2005-01-27 | Progressive Bioactives Incorporated | A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals. |
| US20050058671A1 (en) | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
| US20050065114A1 (en) | 2003-09-23 | 2005-03-24 | Jean-Claude Yvin | Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment |
| US20050095250A1 (en) | 2003-10-30 | 2005-05-05 | Jean-Claude Yvin | Therapeutical combination against cancer |
| US20050118326A1 (en) | 2003-10-16 | 2005-06-02 | Anfinsen Jon R. | Reduced digestible carbohydrate food having reduced blood glucose response |
| US6939864B1 (en) | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
| US20050208079A1 (en) | 2002-05-15 | 2005-09-22 | Antonio Cassone | Glucan-based vaccines |
| WO2007057873A2 (fr) * | 2005-11-21 | 2007-05-24 | Bioatlantis Limited | Nouvelles compositions destinees a ameliorer la sante de l’intestin et la performance des animaux et leur procede de fabrication |
| WO2010133359A2 (fr) * | 2009-05-21 | 2010-11-25 | Bioatlantis Ltd | Amélioration de la santé gastro-intestinale, renforcement de l'immunité et des performances sous l'effet d'une intervention de nature diététique |
-
2022
- 2022-07-20 WO PCT/IB2022/000421 patent/WO2023002252A1/fr unknown
Patent Citations (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB727013A (en) | 1949-11-28 | 1955-03-30 | Nat Res Dev | An improved process for the extraction of mannitol, laminarin and alginic acid from seaweed |
| US4739046A (en) | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
| US4761042A (en) | 1986-02-25 | 1988-08-02 | Alfred Teves Gmbh | Anti-lock hydraulic brake system |
| US4891220A (en) | 1988-07-14 | 1990-01-02 | Immudyne, Inc. | Method and composition for treating hyperlipidemia |
| US5633369A (en) | 1989-09-08 | 1997-05-27 | Alpha-Beta Technology, Inc. | Method for producing soluble glucans |
| US6143731A (en) | 1989-10-20 | 2000-11-07 | The Collaborative Group, Ltd. | Glucan dietary additives |
| US5591428A (en) | 1991-07-25 | 1997-01-07 | Probi Ab | Intestine colonizing lactobacilli |
| US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
| US20020032170A1 (en) | 1992-08-21 | 2002-03-14 | Spiros Jamas | Underivatized, aqueous soluble beta (1-3) glucan, composition and method of making same |
| US5705184A (en) | 1995-03-02 | 1998-01-06 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
| US20040082539A1 (en) | 1995-03-13 | 2004-04-29 | Novogen Research Party, Ltd. | Novel therapeutic uses of glucan |
| US6214337B1 (en) | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
| US6383538B1 (en) | 1998-02-27 | 2002-05-07 | Texas Tech University | Producing meat with enhanced shelf-life |
| US6338856B1 (en) | 1998-02-27 | 2002-01-15 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US6342242B1 (en) | 1998-02-27 | 2002-01-29 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US20020022049A1 (en) | 1998-02-27 | 2002-02-21 | Allen Vivien Gore | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US6312709B1 (en) | 1998-02-27 | 2001-11-06 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US6391331B1 (en) | 1998-02-27 | 2002-05-21 | Texas Tech University | Direct feeding of seaweed supplement to cattle and swine to enhance carcass quality |
| US6432443B1 (en) | 1998-02-27 | 2002-08-13 | Texas Tech University | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US20030003134A1 (en) | 1998-02-27 | 2003-01-02 | Allen Vivien Gore | Seaweed supplement diet for enhancing immune response in mammals and poultry |
| US20020143174A1 (en) | 1998-09-25 | 2002-10-03 | Biopolymer Engineering, Inc. | Very high molecular weight beta-glucans |
| US20010016220A1 (en) | 1999-12-22 | 2001-08-23 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Encapsulated multifunctional biologically active food component, process for its production and its use |
| US6841181B2 (en) | 1999-12-22 | 2005-01-11 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Encapsulated multifunctional biologically active food component, process for its production and its use |
| US6270812B1 (en) | 2000-01-31 | 2001-08-07 | Texas Tech University | Reducing E. coli content of beef |
| US20040127457A1 (en) | 2000-11-03 | 2004-07-01 | Jean-Claude Yvin | Anti-inflammatory and healing medicine based on laminarin sulphate |
| US20020146484A1 (en) | 2001-01-02 | 2002-10-10 | Fidler Daniel J. | Concentrated spent fermentation beer of saccharopolyspora erythraea activated by an enzyme mixture as a nutitional feed supplement |
| US20040138172A1 (en) | 2001-06-01 | 2004-07-15 | Yukie Murata | Drug product for intestinal disease |
| US6939864B1 (en) | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
| US20030119780A1 (en) | 2001-11-30 | 2003-06-26 | Jean-Claude Yvin | Therapeutical treatments |
| US20030124170A1 (en) | 2001-12-19 | 2003-07-03 | Gallaher Daniel D. | Methods to reduce body fat |
| US20040086491A2 (en) | 2002-02-05 | 2004-05-06 | Corpak Medsystems, Inc. | Probiotic/Prebiotic Composition and Delivery Method |
| US20050208079A1 (en) | 2002-05-15 | 2005-09-22 | Antonio Cassone | Glucan-based vaccines |
| US20030219468A1 (en) | 2002-05-21 | 2003-11-27 | Raczek Nico N. | B-glucan-containing sorbic acid preparation as feed additive in farm animal rearing |
| US20040008253A1 (en) | 2002-07-10 | 2004-01-15 | Monroe David A. | Comprehensive multi-media surveillance and response system for aircraft, operations centers, airports and other commercial transports, centers and terminals |
| US20040058889A1 (en) | 2002-09-20 | 2004-03-25 | Nino Sorgente | Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| US20050058671A1 (en) | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
| US20040253253A1 (en) | 2003-06-11 | 2004-12-16 | Cheung Ling Yuk | Biological compositions and methods for treatment of stomach cancer |
| US20050065114A1 (en) | 2003-09-23 | 2005-03-24 | Jean-Claude Yvin | Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment |
| US20050118326A1 (en) | 2003-10-16 | 2005-06-02 | Anfinsen Jon R. | Reduced digestible carbohydrate food having reduced blood glucose response |
| US20050095250A1 (en) | 2003-10-30 | 2005-05-05 | Jean-Claude Yvin | Therapeutical combination against cancer |
| US20050020490A1 (en) | 2004-10-18 | 2005-01-27 | Progressive Bioactives Incorporated | A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals. |
| WO2007057873A2 (fr) * | 2005-11-21 | 2007-05-24 | Bioatlantis Limited | Nouvelles compositions destinees a ameliorer la sante de l’intestin et la performance des animaux et leur procede de fabrication |
| WO2010133359A2 (fr) * | 2009-05-21 | 2010-11-25 | Bioatlantis Ltd | Amélioration de la santé gastro-intestinale, renforcement de l'immunité et des performances sous l'effet d'une intervention de nature diététique |
Non-Patent Citations (106)
| Title |
|---|
| AUTIO, K.MANNONEN, I.PIERILA, K.KOSINKEN, M.SIIKA-AHO, M.LINKO, M., JOURNAL OF THE INSTITUTE OF BREWING, vol. 102, 1996, pages 427 - 432 |
| BACH KNUDSEN, K. E.HANSEN, I, BRITISH JOURNAL OF NUTRITION, vol. 65, 1991, pages 217 - 232 |
| BEDFORD, M. R., ANIMAL FEED SCIENCE AND TECHNOLOGY, vol. 86, 2000, pages 1 - 13 |
| BERGH M. O.RAZDAN A.AMAN P, ANIMAL FEED SCIENCE AND TECHNOLOGY, vol. 201, 1999, pages 215 - 226 |
| BLONDEN CCHAUBET FNARDELLA, ASINQUIN CJOZEFONVIZC, J, BIOMATERIALS, vol. 17, 1996, pages 597 - 603 |
| BOUWHUIS M. A. ET AL: "The effect of maternal and postweaning seaweed extract supplementation on gut health in pigs after weaning and response to enterotoxigenic Escherichia coli K88 challenge.", JOURNAL OF ANIMAL SCIENCE, 1 September 2016 (2016-09-01), pages 395 - 398, XP055971322, Retrieved from the Internet <URL:https://academic.oup.com/jas/article-abstract/94/suppl_3/395/4731484?redirectedFrom=PDF> [retrieved on 20221014], DOI: 10.2527/jas2015-9870 * |
| BOUWHUIS, M. A.SWEENEY, T.MCDONNELL, M. J.DOYLE, D. N.THORNTON, K.MUKHOPADHYA, A.O'DOHERTY, J. V: "The effect of maternal and postweaning seaweed extract supplementation on gut health in pigs after weaning and response to enterotoxigenic Escherichia coli K88 challenge 1", JOURNAL OF ANIMAL SCIENCE, vol. 94, 2016, pages 395 - 398 |
| BROWNLEE I. AALLEN APEARSON J. PDETTMAR P. WHAVLER M. R.ATHERTON M. EONSOYEN E, CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, vol. 45, 2005, pages 497 - 510 |
| BURTIN, P., ELECTRONIC JOURNAL OF ENVIRONMENTAL AGRICULTURE AND FOOD CHEMISTRY, vol. 2, 2003 |
| CAMPBELL, G. L.BEDFORD, M. R., CANADIAN JOURNAL OF ANIMAL SCIENCE, vol. 72, 1992, pages 449 - 466 |
| CANH, T. T.SUTTON, A. L.AARNINK, A. J. A.VERSTEGEN, M. W. A.SCHRAMA, J. W.BAKKER, G. C. M., JOURNAL OF ANIMAL SCIENCE, vol. 76, 1998, pages 1331 - 1342 |
| CATHERINE MICHELMARC LAHAYECHRISTIAN BONNETTSERGE MABEAUJEAN-LUC BERRY, BRITISH JOURNAL OF NUTRITION, vol. 75, 1996, pages 263 - 280 |
| CHARALAMPOPULOUS, D.WANG, RPANDIELLA, S. SWEBB, C., INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, vol. 79, 2002, pages 131 - 141 |
| CHOCT, M., FEED MILLING INTERNATIONAL, June 1997 (1997-06-01), pages 13 - 26 |
| CLOSE, W. H., ADVANCES IN PORK PRODUCTION, vol. 11, 2000, pages 47 - 56 |
| COLE, D. J. A.BEAL, R. M.LUSCOMBE, J. R., VETERINARY RECORD, vol. 83, 1968, pages 459 - 464 |
| CONWAY, E. J.: "Microdiffusion Analysis and Volumetric Error", 1957, CROSBY LOCKWOOD AND SON, pages: 465 |
| CUI, W.WOOD, P. J.BLACKWELL, B.NILIFORUK, J., CARBOHYDRATE POLYMERS, vol. 41, no. 3, 2000, pages 249 - 258 |
| DARCY-VRILLON, B.VAUGELADE, P.BERNARD, F.HOEBLER, C.GUILLON, F.MABEAU, SDUEE, P-H., REPRODUCTION NUTRITION DEVELOPMENT, vol. 36, 1996, pages 425 |
| DE MITCHELL, I.R. KENWORTHY, JOURNAL OF APPLIED BACTERIOLOGY, vol. 41, 1976, pages 163 - 174 |
| DIERICK, N.DECUYPERE, J., PIG NEWS INFORMATION, vol. 17, 1996, pages 41N - 48N |
| DREW, M. D.A. G. VAN KESSELA. E. ESTRADAE. D. EKPER. T. ZIJLSTRA, CANADIAN JOURNAL OF ANIMAL SCIENCE, vol. 82, 2003, pages 607 - 609 |
| DROCHNER, W.KERLER, A.ZACHARIAS, B., JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION, vol. 88, 2004, pages 367 - 380 |
| ESTRADA, A.DREW, M. D.VAN KESSEL., CANADIAN JOURNAL OF ANIMAL SCIENCE, vol. 81, 2001, pages 141 - 148 |
| ETHERIDGE, R. D.SEERLEY, R. W.WYATT, R. D., JOURNAL OF ANIMAL SCIENCE, vol. 58, no. 6, 1984, pages 1396 - 1402 |
| FREIMUND SSAUTER MKAPPELI ODUTLER H, CARBOHYDRATE POLYMERS, vol. 54, 2003, pages 159 - 171 |
| GAO, Y.LACKEYRAM, D.RIDEOUT, T.ARCHBOLD, T.DUNS, G.FAN, M. Z.SQUIRES, E. J.DE LANGE, C. F. M.SMITH, T. K.: "Digestive Physiology in Pigs, Proceedings of the 8.sup.th symposium on digestive physiology in pigs", CAB INTERNATIONAL, WALLINGFORD, UK, 2001, pages 338 - 340 |
| GIBSON, G. R.ROBERFROID, M. B., JOURNAL OF NUTRITION, vol. 125, 1995, pages 1401 - 1412 |
| GLISTO, L. V.BRUNSGAARD, G.HOJSGAARD, S.SANDSTROM, B.BACH KNUDSEN, K. E., BRITISH JOURNAL OF NUTRITION, vol. 80, 1998, pages 457 - 468 |
| GRAHAM, H.PETTERSSON, D., SWEDISH JOURNAL OF AGRICULTURAL RESEARCH, vol. 22, 1992, pages 39 - 42 |
| GRAY, J.: "Carbohydrates: Nutritional and health aspects", 1 January 2003, INTERNATIONAL LIFE SCIENCE INSTITUTE |
| HAYES, E. T.LEEK, A. B. G.CURREN, T. P.DODD, V. A.CARTON, O. T.BEATTIE, V. EO'DOHERTY, J. V, BIORESOURCE TECHNOLOGY, vol. 91, 2004, pages 309 - 315 |
| HEO, S-J.PARK, E-J.LEE, K-W.JEON, Y-J., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 1613 - 1623 |
| HISS, S.SAUERWEIN, H., JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION, vol. 87, 2003, pages 2 - 11 |
| HOBBS, P. J.MISSLEBROOK, T. H.PAIN, B. F., JOURNAL OF AGRICULTURAL ENGINEERING RESEARCH, vol. 60, 1995, pages 137 - 144 |
| HOGBERG ALINDBERG J E, ANIMAL FEED SCIENCE AND TECHNOLOGY, 2005 |
| HOUDIJK, J. G. M.BOSCH, M. W.VERSTEGEN, M. W. A.BERENPAS, H. J., ANIMAL FEED SCIENCE AND TECHNOLOGY, vol. 71, 1998, pages 35 - 48 |
| ITO, K.HORI, K., FOOD REVIEWS INTERNATIONAL, vol. 5, 1989, pages 101 - 144 |
| ITOH, HIROKO ET AL., ANTICANCER RESEARCH, vol. 13, 1993, pages 2045 - 2052 |
| JAMROZ, D.WILICZKIEWICZ, A.ORDA, J.SKORUPINSKA, J., WIEN. TIERARZTL. MSCHR., vol. 83, 1996 |
| JAMROZ, D.WILICZKIEWICZ, A.SKORUPINSKA, J., J. ANIM. FEED SCI., vol. 1, no. 37, 1992, pages 50 |
| JASKARI, J.P. KONTULAA. SIITONENH. JOUSIMEIES-SOMERT. MATTILA-SANDHOLMK. POUTANEN, APPLIED MICROBIOLOGY BIOTECHNOLOGY, vol. 49, 1998, pages 175 - 181 |
| JENSEN, B. B.H. JORGENSEN, APPLIED ENVIRON. MICROBIOL., vol. 60, 1994, pages 1897 - 1904 |
| KENWORTHY, R.W. E. CRABB, JOURNAL OF COMPARATIVE PATHOLOGY, vol. 73, 1963, pages 215 - 228 |
| KIM, I I.JEWELL, D. E.BENEVENGA, N. J.GRUMMER, R. H., JOURNAL OF ANIMAL SCIENCE, vol. 46, 1978, pages 1658 - 1665 |
| LAURIE O'SULLIVAN ET AL: "Prebiotics from Marine Macroalgae for Human and Animal Health Applications", MARINE DRUGS, vol. 8, no. 7, 1 July 2010 (2010-07-01), pages 2038 - 2064, XP055387476, DOI: 10.3390/md8072038 * |
| LEONARD, S. G.SWEENEY, T.BAHAR, B.LYNCH, B. PO'DOHERTY, J. V.: "Effects of dietary seaweed extract supplementation in sows and post-weaned pigs on performance, intestinal morphology, intestinal microflora and immune status", BRITISH JOURNAL OF NUTRITION, vol. 106, 2011, pages 688 - 699 |
| LLAUBE'RES, R. M.RICHARD, B.LONVAUD, A.DUBOURDIEU, D.FOURNET, B., CARBOHYDRATE RESEARCH, vol. 203, 1990, pages 103 - 107 |
| LÓPEZ-GÁLVEZ GLORIA ET AL: "Alternatives to antibiotics and trace elements (copper and zinc) to improve gut health and zootechnical parameters in piglets: A review", ANIMAL FEED SCIENCE AND TECHNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 271, 24 October 2020 (2020-10-24), XP086443435, ISSN: 0377-8401, [retrieved on 20201024], DOI: 10.1016/J.ANIFEEDSCI.2020.114727 * |
| MABEAU, S.KLOAREG, B. J., EXP. BOT., vol. 38, 1987, pages 1573 - 1580 |
| MAGNELLI PCIPOLLO J. F.ABEIJON C., ANALYTICAL BIOCHEMISTRY, vol. 301, 2002, pages 136 - 150 |
| MAHAN, D. C., JOURNAL OF ANIMAL SCIENCE, vol. 70, 1992, pages 2182 - 2187 |
| MAHAN, D. CNEWTON, E. A., JOURNAL OF ANIMAL SCIENCE, vol. 71, 1993, pages 3376 - 3382 |
| MARTENSSON OBIORKLUND MLAMBO M ADUENAS-CHASCO MIRASTORZA AM HOIST ONORIN EWELLING GOSTE RONNING G, NUTRITION RESEARCH, vol. 25, 2005, pages 429 - 442 |
| MATHERS, J. C.ANNISON, E. F.: "Dietary fibre and beyond--Australian perspectives", 1993, NUTRITION SOCIETY OF AUSTRALIA OCCASIONAL PUBLICATIONS, article "Stoichiometry of polysaccharide fermentation in the large intestine", pages: 123 - 125 |
| MATHERS, J. CANNISONN E. F.: "Stoichiometry of polysaccharide fementation in the large intestine", DIETARY FIBRE AND BEYOND--AUSTRALIAN PERSPECTIVES, vol. 1, 1993, pages 123 - 135 |
| MC CRACKEN, B. ASPURLOCK, M. E.ROOS, M. A.ZUCKERMANN, F. A.GASKINS, H. R., JOURNAL OF NUTRITION, vol. 129, 1999, pages 613 - 619 |
| MELIN, L.MATTISSON, S.KATOULI, M.WALLGREN, P., JOURNAL OF VETERINARY MEDICINE, vol. B51, 2004, pages 12 - 22 |
| MIKLKESEN, L. L.JENSEN, B. B.: "Proceedings of the International Symposium Non-digestible Oligosaccharides: Healthy food for the colon?", 1997, article "Effect of fructo-oligosaccharide (FO) on the intestinal microbiota of rats and determination of the fermentative transformation and energy transmission of FO", pages: 158 |
| MINISTRY OF AGRICULTURE, FISHERIES AND FOOD, 1991 |
| MONTAGNE, L.PLUSKE, J. R.HAMPSON, D. J., ANIMAL FEED SCIENCE AND TECHNOLOGY, vol. 108, 2003, pages 95 - 117 |
| MORTENSEN, P. B.HOVE, H.CLAUSEN, M. R.HOLTUG, K., SCANDANAVIAN JOURNAL OF GASTROENTEROLOGY, vol. 26, no. 12, 1991, pages 1285 - 1294 |
| MROZ, Z.MOESER, A. J.VREMAN, K.VAN DIEPEN, J. T. M.VAN KEMPEN, T.CANH, T. T.JONGBLOED, A. W., JOURNAL OF ANIMAL SCIENCE, vol. 78, 2000, pages 3096 - 3106 |
| MULLER AENSLEY HPRETUS HMCNAMEE RJONES EMCLAUGHLIN ECHANDLEY WBROWDER WLOWMAN DWILLIAMS D, CARBOHYDRATE RESEARCH, vol. 299, 1997, pages 203 - 208 |
| MURALIDHARA, K. S.G. G. SHEGGEBYP. R. ELLIKERD. C. ENGLANDW. E. SANDINE, JOURNAL OF FOODPROTECTION, vol. 40, 1977, pages 288 - 295 |
| NAHM, K. H., CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY, vol. 30, no. 2, 2003, pages 165 - 186 |
| NESSMITH JR, W. B.NELSSEN, J. L.TOKACH, M. D.GOODBAND, R. DBERGSTROM, J. R., JOURNAL OF ANIMAL SCIENCE, vol. 75, 1997, pages 3222 - 3228 |
| O'DOHERTY, J. V.NOLAN, C. SCALLAN, J. JMCCARTHY, P., ANIMAL SCIENCE, vol. 78, 2004, pages 419 - 428 |
| ONNING, G.ASP, N. G., BRITISH JOURNAL OF NUTRITION, vol. 74, 1995, pages 229 - 237 |
| O'SHEA, C. J.MCALPINE, P.SWEENEY, T.VARLEY, P. F.O'DOHERTY, J. V: "Effect of the interaction of seaweed extracts containing laminarin and fucoidan with zinc oxide on the growth performance, digestibility and faecal characteristics of growing piglets", BRITISH JOURNAL OF NUTRITION, vol. 111, 2014, pages 798 - 807 |
| OWSLEY, W. F.ORR, D. E.TRIBBLE, L. F., JOURNAL OF ANIMAL SCIENCE, vol. 63, 1986, pages 492 - 496 |
| PACHECO-DELAYAYE, E., FOOD CHEMISTRY, vol. 65, 1995, pages 433 - 437 |
| PARTRIDGE, G. GGILL, B. P.: "Recent Developments in Pig Nutrition", vol. 3, 1993, NOTTINGHAM UNIVERSITY PRESS, pages: 205 - 237 |
| PEREIRA, MARIANA S. ET AL., J. BIOL. CHEM., vol. 274, no. 12, 1999, pages 7656 - 7667 |
| PETTERSSON ALINDBERG J E, ANIMAL FEED SCIENCE TECHNOLOGY, vol. 66, 1997, pages 97 - 109 |
| PETTERSSON, D.P. AMAN, BRITISH JOURNAL OF NUTRITION, vol. 62, 1989, pages 139 - 149 |
| PIERCE, AILEEN: "MsC Thesis", 2002, NATIONAL UNIVERSITY OF IRELAND, article "The use of seaweed extract in animal nutrition" |
| PIERCE, K. M.CALLAN, J. J.BROPHY, P. O.MCCARTHY, P.SWEENEY, T.FITZPATRICK, E.BYRNE, C.NI CHEALLAIGH, S.O'DOHERTY, J. V, JOURNAL OF ANIMAL SCIENCE, vol. 1, 2004, pages 138 - 139 |
| PITCAIRN, C. E. R.SKIBA, U. MSUTTON, M. A.FOWLER, D.MUNRO, R.KENNEDY, V, ENVIRONMENTAL POLLUTION, vol. 119, 2002, pages 9 - 21 |
| PLUSKE, J. R.HAMPSON, D. JWILLIAMS I. H, LIVESTOCK PRODUCTION SCIENCE, vol. 51, 1997, pages 215 - 236 |
| PLUSKE, J. R.WILLIAMS, I. H.AHERNE, F. A.: "The neonatal pigs: development and survival", 1995, CAB INTERNATIONAL, article "Nutrition of the neonatal pig" |
| PORTER, M. G.MURRAY, R. S., GRASS AND FORAGE SCIENCE, vol. 56, 2001, pages 405 - 411 |
| READ SCURRIE GBACIC A., CARBOHYDRATE RESEARCH, vol. 281, 1996, pages 187 - 210 |
| RIOU, D. ET AL., ANTICANCER RESEARCH, vol. 16, 1996, pages 1213 - 1218 |
| S. COLLIEC ET AL., PHYTOCHEMISTRY, vol. 35, 1994, pages 697 - 700 |
| SAUER, W. C.JUST, A.JORGENSEN, H. H.FEKADU, M.EGGUM, B. O., JOURNAL OF ANIMAL SCIENCE, vol. 69, 1980, pages 4070 - 4079 |
| SCHMITZ, W.: "TNO Nutrition and Food Research Institute, Zeist, The Netherlands", 1995, article "Proceedings of the second European symposium on feed enzymes", pages: 95 - 101 |
| SHIBATA, HIDEYULD, J. NUTR. SCI. VITAMINOL., vol. 45, 1999, pages 325 - 336 |
| SMITH, E. A.MACFARLANE, G. T., ANAEROBE, vol. 3, 1997, pages 327 - 337 |
| SOERGEL, K. H., CLINICAL INVESTIGATIONS, vol. 72, 1994, pages 742 - 748 |
| SOMOGYI, M., CLINICAL CHEMISTRY, vol. 6, 1960, pages 23 - 35 |
| SPREEUWENBERG, M. A. M.VERDONK, J. M. A. J.GASKINS, J. H.VERSTEGEN, M. W. A., JOURNAL OF NUTRITION, vol. 131, 2001, pages 1520 - 1527 |
| STANOGIAS, G.PEARCE G. R.: "British Journal of Nutrition", vol. 53, 1985, SAS INSTITUTE INC., article "Statistics Analysis Systems Institute", pages: 537 - 548 |
| THEANDER OWESTERLUND EAMAN PGRAHAM H, ANIMAL FEED SCIENCE AND TECHNOLOGY, vol. 23, 1989, pages 205 - 225 |
| THOMLINSON, J. R., THE VETERINARY RECORD, vol. 109, 1981, pages 120 - 122 |
| TOKACH, M. D.NELSSEN, J. L.ALLEE, G. L., JOURNAL OF ANIMAL SCIENCE, vol. 67, 1989, pages 1307 - 1312 |
| TURNER, J. L.DRITZ, J. J.HIGGINSMINTON, J. E., JOURNAL OF ANIMAL SCIENCE, vol. 80, 2002, pages 1947 - 1953 |
| VAN SOEST, P. J., JOURNAL OF THE ASSOCIATION OF AGRICULTURAL CHEMISTS, vol. 46, 1976, pages 829 - 834 |
| VAN SOEST, P. J.ROBERTSON, J. B.LEWIS, B. A., JOURNAL OF DAIRY SCIENCE, vol. 74, 1991, pages 3583 - 3597 |
| VAREL, V. H., JOURNAL OF ANIMAL SCIENCE, vol. 65, 1987, pages 488 - 496 |
| VERSTEGEN, M. W.B. A. WILLIAMS, JOURNAL OF ANIMAL BIOTECHNOLOGY, vol. 13, 2002, pages 113 - 127 |
| WILICZKIEWICZ, A.JAMROZ, D.SKORUPINSKA, J.ORDA, J., WIEN. TIERARZTL. MSCHR, vol. 82, 1995, pages 239 - 244 |
| WILLIAMS, B. A.MARTIN, W. A.VERSTEGENTAMMINGA S, NUTRITION RESEARCH REVIEWS, vol. 14, 2001, pages 207 - 227 |
| WILLIAMS, C. H.DAVID, D. J.IISMAA, O., JOURNAL OF ANIMAL SCIENCE, vol. 59, 1962, pages 381 - 385 |
| ZIJLSTRA, R. T.WHANG, K-Y.EASTER, R. A.ODLE, J., JOURNAL OF ANIMAL SCIENCE, vol. 74, 1996, pages 2948 - 2959 |
| ZVYAGINTSEVA ET AL., CARBOHYDRATE RESEARCH, vol. 322, 1999, pages 32 - 29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10780137B2 (en) | Composition to improve gut health and animal performance and methods of making the same | |
| Vidanarachchi et al. | Phytobiotics: alternatives to antibiotic growth promoters in monogastric animal feeds | |
| JP2018048141A (ja) | 食事介入による胃腸の健康、免疫および働きの改善 | |
| KR20050108423A (ko) | 관절염 예방 또는 치료제 | |
| KR101888549B1 (ko) | 굼벵이를 함유하는 다이어트 음료 및 그 제조방법 | |
| TW201827065A (zh) | 至少一種甘草屬植物製劑之用途、包括該製劑之解毒劑、及該解毒劑之用途 | |
| Kandeil et al. | Ameliorative effects of oral ginger and/or thyme aqueous extracts on productive and reproductive performance of V‐line male rabbits | |
| KR100887854B1 (ko) | 관절염의 예방제 또는 치료제 | |
| CN102429183A (zh) | 一种具有增强免疫力和通便功能的果蔬组合物及其制备方法 | |
| Sugiharto et al. | Hematological and intestinal responses of broilers to dietary supplementations of lactic fermented turmeric, black pepper or a mixture of both. | |
| Allinson et al. | Effect of herbal supplement on growth response and faecal egg counts of cockerels. | |
| US20210346443A1 (en) | Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same | |
| Abd | Effect of effective microorganisms on some biochemical parameters in broiler chicks | |
| Wong et al. | Effect of fiber-rich brown seaweeds on protein bioavailability of casein in growing rats | |
| El-Shafei et al. | Effectiveness of caprylic acid and Yucca schidigera extract on productive and physiological performance of laying hens | |
| WO2023002252A1 (fr) | Composition comprenant des bêta-glucanes et des alpha-fucanes pour amélioration de la santé intestinale et des performances animales et leurs procédés de fabrication | |
| CN114304651A (zh) | 提高免疫力组合物 | |
| Class et al. | Patent application title: Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same Inventors: John O'Doherty (Belfield, IE) John O'Sullivan (Tralee, IE) Aditya Julka (Tralee, IE) Assignees: BIOATLANTIS LIMITED | |
| Oloruntola et al. | Broiler Chickens' Growth, Haematological Indices, Guts Microbiota, Carcass and Meat Analysis in Response to Dietary Supplementation with Anacardium occidentale Leaf Powder and A Mix of Prebiotic, Probiotic and Acidifier | |
| Elnaggar et al. | Impact Of Ginseng (Panax Ginseng) On Growth Performance, Blood Biochemical Parameters And Antioxidative Status Of Japanese Quail | |
| Hassan | Effect of some nutritional treatments of olive cake meal on ducks performance under South Sinai conditions | |
| Puspani et al. | Effect of yeast and multi vitamin-minerals mix in diet to stimulate the growth performance of ducks and suppress pathogenic bacteria | |
| El-Maddawy et al. | Comparative studies of the growth promoting efficiency of Jerusalem Artichoke and 1-3, 1-4, 1-6 yeast beta-glucan on broiler chicks. | |
| Teuchert | Comparison of production parameters, gut histology, organ weights, and portion yields of broilers supplemented with Ateli plus | |
| Novotný et al. | The Effects of Clinoptilolite Administration on the Appetite, the Consistency of Faeces and the Histology of the Small Intestine in Growing Pigs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22758260 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |